Company Overview
Surfagen is a privately held company located in Charleston, South Carolina focusing on the
development of novel nanoparticle systems for the delivery of siRNA therapeutics.
siRNA therapeutics, a recently developed approach for treating major diseases, has created a
great deal of excitement because of its potential to impact the genes responsible for a wide
variety of medical problems. As a result, a great deal of money has been invested, both by
major pharmaceutical companies and private investors, in new companies that are developing
siRNA therapeutics. However, one problem that has prevented siRNA from reaching its
potential is the lack of a good delivery system.
Surfagen , Inc. is developing a new class of novel multifunctional carriers (MFCs) that
overcome the deficiencies of delivery systems for siRNA therapeutics being used by other
companies. This technology was developed at the University of Utah by Surfagen's founding
scientist Dr. Zheng-Rong Lu.
Surfagen is a privately held company located in Charleston, South Carolina focusing on the
development of novel nanoparticle systems for the delivery of siRNA therapeutics.
siRNA therapeutics, a recently developed approach for treating major diseases, has created a
great deal of excitement because of its potential to impact the genes responsible for a wide
variety of medical problems. As a result, a great deal of money has been invested, both by
major pharmaceutical companies and private investors, in new companies that are developing
siRNA therapeutics. However, one problem that has prevented siRNA from reaching its
potential is the lack of a good delivery system.
Surfagen , Inc. is developing a new class of novel multifunctional carriers (MFCs) that
overcome the deficiencies of delivery systems for siRNA therapeutics being used by other
companies. This technology was developed at the University of Utah by Surfagen's founding
scientist Dr. Zheng-Rong Lu.
 | |  | |  | |  | |  |
